China Oncology ›› 2022, Vol. 32 ›› Issue (7): 650-656.doi: 10.19401/j.cnki.1007-3639.2022.07.009

• Case Report • Previous Articles     Next Articles

A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder

LIU Yanquan1,2()(), HU Xiaomei3, YIN Yue4, LIN Lin5, SHEN Jianzhen4, CHEN Yuting1,2, TANG Huanwen1,2()()   

  1. 1. Department of Hematology, First Clinical Medical College, Graduate School of Guangdong Medical University, Dongguan 523808, Guangdong Province, China
    2. Dongguan Key Laboratory of Environmental Medicine of Guangdong Province, Dongguan 523808, Guangdong Province, China
    3. Department of Pathology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China
    4. Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China
    5. Department of Medical Imaging, Fujian Medical University Union Hospital, Fuzhou 350001, Fujian Province, China
  • Received:2022-03-26 Online:2022-07-30 Published:2022-08-09
  • Contact: TANG Huanwen E-mail:doctorliuyanquan@163.com;thw@gdmu.edu.cn

Key words: Post-transplant lymphoproliferative disorder, Organ transplantation, Extranodal lymphoma, Differential diagnosis, Prognosis

CLC Number: